The Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oral Vaccines size is estimated to be XX million in 2021 from USD 2392.3 million in 2020, with a change of XX% between 2020 and 2021. The global Oral Vaccines market size is expected to grow at a CAGR of 4.1% for the next five years.
Market segmentation
Oral Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
Market segment by Application can be divided into
- Public
- Private
The key market players for global Oral Vaccines market are listed below:
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
Market segment by Region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oral Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Vaccines, with price, sales, revenue and global market share of Oral Vaccines from 2019 to 2021.
Chapter 3, the Oral Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oral Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Global Oral Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
Table of Contents
1 Market Overview
1.1 Oral Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccines Market Size & Forecast
1.4.1 Global Oral Vaccines Sales in Value (2016-2026))
1.4.2 Global Oral Vaccines Sales in Volume (2016-2026)
1.4.3 Global Oral Vaccines Price by Type (2016-2026) & (USD/K Doses)
1.5 Global Oral Vaccines Production Capacity Analysis
1.5.1 Global Oral Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Oral Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Vaccines Market Drivers
1.6.2 Oral Vaccines Market Restraints
1.6.3 Oral Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Oral Vaccines Product and Services
2.1.4 Merck Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Oral Vaccines Product and Services
2.2.4 GSK Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Oral Vaccines Product and Services
2.3.4 Sanofi Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Lanzhou Institute
2.4.1 Lanzhou Institute Details
2.4.2 Lanzhou Institute Major Business
2.4.3 Lanzhou Institute Oral Vaccines Product and Services
2.4.4 Lanzhou Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute Oral Vaccines Product and Services
2.5.4 Serum Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Valneva
2.6.1 Valneva Details
2.6.2 Valneva Major Business
2.6.3 Valneva Oral Vaccines Product and Services
2.6.4 Valneva Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business
2.7.3 Shanghai United Cell Oral Vaccines Product and Services
2.7.4 Shanghai United Cell Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Bibcol
2.8.1 Bibcol Details
2.8.2 Bibcol Major Business
2.8.3 Bibcol Oral Vaccines Product and Services
2.8.4 Bibcol Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 PaxVax
2.9.1 PaxVax Details
2.9.2 PaxVax Major Business
2.9.3 PaxVax Oral Vaccines Product and Services
2.9.4 PaxVax Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Vabiotech
2.10.1 Vabiotech Details
2.10.2 Vabiotech Major Business
2.10.3 Vabiotech Oral Vaccines Product and Services
2.10.4 Vabiotech Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Tiantan Biological
2.11.1 Tiantan Biological Details
2.11.2 Tiantan Biological Major Business
2.11.3 Tiantan Biological Oral Vaccines Product and Services
2.11.4 Tiantan Biological Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 EuBiologics
2.12.1 EuBiologics Details
2.12.2 EuBiologics Major Business
2.12.3 EuBiologics Oral Vaccines Product and Services
2.12.4 EuBiologics Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Panacea Biotec Ltd
2.13.1 Panacea Biotec Ltd Details
2.13.2 Panacea Biotec Ltd Major Business
2.13.3 Panacea Biotec Ltd Oral Vaccines Product and Services
2.13.4 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Bio-Med
2.14.1 Bio-Med Details
2.14.2 Bio-Med Major Business
2.14.3 Bio-Med Oral Vaccines Product and Services
2.14.4 Bio-Med Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Halfkin Bio-Pharmaceuticals
2.15.1 Halfkin Bio-Pharmaceuticals Details
2.15.2 Halfkin Bio-Pharmaceuticals Major Business
2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
2.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Oral Vaccines Sales by Manufacturer
3.1 Global Oral Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oral Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oral Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Vaccines Manufacturer Market Share
3.4.2 Top 6 Oral Vaccines Manufacturer Market Share
3.5 Global Oral Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oral Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Vaccines Market Size by Region
4.1.1 Global Oral Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Oral Vaccines Revenue by Region (2016-2026)
4.2 North America Oral Vaccines Revenue (2016-2026)
4.3 Europe Oral Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Oral Vaccines Revenue (2016-2026)
4.5 South America Oral Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Oral Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oral Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Oral Vaccines Revenue by Type (2016-2026)
5.3 Global Oral Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oral Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Oral Vaccines Revenue by Application (2016-2026)
6.3 Global Oral Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oral Vaccines Sales by Type (2016-2026)
7.2 North America Oral Vaccines Sales by Application (2016-2026)
7.3 North America Oral Vaccines Market Size by Country
7.3.1 North America Oral Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Oral Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Vaccines Sales by Type (2016-2026)
8.2 Europe Oral Vaccines Sales by Application (2016-2026)
8.3 Europe Oral Vaccines Market Size by Country
8.3.1 Europe Oral Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Oral Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oral Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Oral Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Oral Vaccines Market Size by Region
9.3.1 Asia-Pacific Oral Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oral Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oral Vaccines Sales by Type (2016-2026)
10.2 South America Oral Vaccines Sales by Application (2016-2026)
10.3 South America Oral Vaccines Market Size by Country
10.3.1 South America Oral Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Oral Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Oral Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Oral Vaccines Market Size by Country
11.3.1 Middle East & Africa Oral Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oral Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oral Vaccines Typical Distributors
12.3 Oral Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Oral Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oral Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Oral Vaccines Product and Services
Table 6. Merck Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Oral Vaccines Product and Services
Table 10. GSK Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Oral Vaccines Product and Services
Table 14. Sanofi Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 16. Lanzhou Institute Major Business
Table 17. Lanzhou Institute Oral Vaccines Product and Services
Table 18. Lanzhou Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute Major Business
Table 21. Serum Institute Oral Vaccines Product and Services
Table 22. Serum Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Valneva Basic Information, Manufacturing Base and Competitors
Table 24. Valneva Major Business
Table 25. Valneva Oral Vaccines Product and Services
Table 26. Valneva Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 28. Shanghai United Cell Major Business
Table 29. Shanghai United Cell Oral Vaccines Product and Services
Table 30. Shanghai United Cell Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bibcol Basic Information, Manufacturing Base and Competitors
Table 32. Bibcol Major Business
Table 33. Bibcol Oral Vaccines Product and Services
Table 34. Bibcol Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. PaxVax Basic Information, Manufacturing Base and Competitors
Table 36. PaxVax Major Business
Table 37. PaxVax Oral Vaccines Product and Services
Table 38. PaxVax Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 40. Vabiotech Major Business
Table 41. Vabiotech Oral Vaccines Product and Services
Table 42. Vabiotech Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 44. Tiantan Biological Major Business
Table 45. Tiantan Biological Oral Vaccines Product and Services
Table 46. Tiantan Biological Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 48. EuBiologics Major Business
Table 49. EuBiologics Oral Vaccines Product and Services
Table 50. EuBiologics Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Panacea Biotec Ltd Major Business
Table 53. Panacea Biotec Ltd Oral Vaccines Product and Services
Table 54. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 56. Bio-Med Major Business
Table 57. Bio-Med Oral Vaccines Product and Services
Table 58. Bio-Med Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Halfkin Bio-Pharmaceuticals Major Business
Table 61. Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
Table 62. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Oral Vaccines Sales by Manufacturer (2019-2021e) & (M Doses)
Table 64. Global Oral Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Oral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Oral Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021
Table 67. Head Office and Oral Vaccines Production Site of Key Manufacturer
Table 68. Oral Vaccines New Entrant and Capacity Expansion Plans
Table 69. Oral Vaccines Mergers & Acquisitions in the Past Five Years
Table 70. Global Oral Vaccines Sales by Region (2016-2021e) & (M Doses)
Table 71. Global Oral Vaccines Sales by Region (2021-2026) & (M Doses)
Table 72. Global Oral Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Oral Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Oral Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 75. Global Oral Vaccines Sales by Type (2021-2026) & (M Doses)
Table 76. Global Oral Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Oral Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Oral Vaccines Price by Type (2016-2021e) & (USD/K Doses)
Table 79. Global Oral Vaccines Price by Type (2021-2026) & (USD/K Doses)
Table 80. Global Oral Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 81. Global Oral Vaccines Sales by Application (2021-2026) & (M Doses)
Table 82. Global Oral Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Oral Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Oral Vaccines Price by Application (2016-2021e) & (USD/K Doses)
Table 85. Global Oral Vaccines Price by Application (2021-2026) & (USD/K Doses)
Table 86. North America Oral Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 87. North America Oral Vaccines Sales by Country (2021-2026) & (M Doses)
Table 88. North America Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Oral Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 91. North America Oral Vaccines Sales by Type (2021-2026) & (M Doses)
Table 92. North America Oral Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 93. North America Oral Vaccines Sales by Application (2021-2026) & (M Doses)
Table 94. Europe Oral Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 95. Europe Oral Vaccines Sales by Country (2021-2026) & (M Doses)
Table 96. Europe Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Oral Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 99. Europe Oral Vaccines Sales by Type (2021-2026) & (M Doses)
Table 100. Europe Oral Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 101. Europe Oral Vaccines Sales by Application (2021-2026) & (M Doses)
Table 102. Asia-Pacific Oral Vaccines Sales by Region (2016-2021e) & (M Doses)
Table 103. Asia-Pacific Oral Vaccines Sales by Region (2021-2026) & (M Doses)
Table 104. Asia-Pacific Oral Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Oral Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Oral Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 107. Asia-Pacific Oral Vaccines Sales by Type (2021-2026) & (M Doses)
Table 108. Asia-Pacific Oral Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 109. Asia-Pacific Oral Vaccines Sales by Application (2021-2026) & (M Doses)
Table 110. South America Oral Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 111. South America Oral Vaccines Sales by Country (2021-2026) & (M Doses)
Table 112. South America Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Oral Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 115. South America Oral Vaccines Sales by Type (2021-2026) & (M Doses)
Table 116. South America Oral Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 117. South America Oral Vaccines Sales by Application (2021-2026) & (M Doses)
Table 118. Middle East & Africa Oral Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 119. Middle East & Africa Oral Vaccines Sales by Country (2021-2026) & (M Doses)
Table 120. Middle East & Africa Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Oral Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 123. Middle East & Africa Oral Vaccines Sales by Type (2021-2026) & (M Doses)
Table 124. Middle East & Africa Oral Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 125. Middle East & Africa Oral Vaccines Sales by Application (2021-2026) & (M Doses)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Oral Vaccines Typical Distributors
Table 129. Oral Vaccines Typical Customers
List of Figures
Figure 1. Oral Vaccines Picture
Figure 2. Global Oral Vaccines Sales Market Share by Type in 2020
Figure 3. Rotavirus Vaccine
Figure 4. Cholera Vaccine
Figure 5. Oral Polio Vaccine
Figure 6. Global Oral Vaccines Sales Market Share by Application in 2020
Figure 7. Public
Figure 8. Private
Figure 9. Global Oral Vaccines Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 10. Global Oral Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Oral Vaccines Sales (2016-2026) & (M Doses)
Figure 12. Global Oral Vaccines Price by Type (2016-2026) & (USD/K Doses)
Figure 13. Global Oral Vaccines Production Capacity (2016-2026) & (M Doses)
Figure 14. Global Oral Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Oral Vaccines Market Drivers
Figure 16. Oral Vaccines Market Restraints
Figure 17. Oral Vaccines Market Trends
Figure 18. Global Oral Vaccines Sales Market Share by Manufacturer in 2020
Figure 19. Global Oral Vaccines Revenue Market Share by Manufacturer in 2020
Figure 20. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Oral Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Oral Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Oral Vaccines Sales Market Share by Region (2016-2026)
Figure 24. Global Oral Vaccines Revenue Market Share by Region (2016-2026)
Figure 25. North America Oral Vaccines Revenue (2016-2026) & (USD Million)
Figure 26. Europe Oral Vaccines Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Oral Vaccines Revenue (2016-2026) & (USD Million)
Figure 28. South America Oral Vaccines Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Oral Vaccines Revenue (2016-2026) & (USD Million)
Figure 30. Global Oral Vaccines Sales Market Share by Type (2016-2026)
Figure 31. Global Oral Vaccines Revenue Market Share by Type (2016-2026)
Figure 32. Global Oral Vaccines Price by Type (2016-2026) & (USD/K Doses)
Figure 33. Global Oral Vaccines Sales Market Share by Application (2016-2026)
Figure 34. Global Oral Vaccines Revenue Market Share by Application (2016-2026)
Figure 35. Global Oral Vaccines Price by Application (2016-2026) & (USD/K Doses)
Figure 36. North America Oral Vaccines Sales Market Share by Type (2016-2026)
Figure 37. North America Oral Vaccines Sales Market Share by Application (2016-2026)
Figure 38. North America Oral Vaccines Sales Market Share by Country (2016-2026)
Figure 39. North America Oral Vaccines Revenue Market Share by Country (2016-2026)
Figure 40. United States Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Oral Vaccines Sales Market Share by Type (2016-2026)
Figure 44. Europe Oral Vaccines Sales Market Share by Application (2016-2026)
Figure 45. Europe Oral Vaccines Sales Market Share by Country (2016-2026)
Figure 46. Europe Oral Vaccines Revenue Market Share by Country (2016-2026)
Figure 47. Germany Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Oral Vaccines Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Oral Vaccines Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Oral Vaccines Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Oral Vaccines Revenue Market Share by Region (2016-2026)
Figure 56. China Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Oral Vaccines Sales Market Share by Type (2016-2026)
Figure 63. South America Oral Vaccines Sales Market Share by Application (2016-2026)
Figure 64. South America Oral Vaccines Sales Market Share by Country (2016-2026)
Figure 65. South America Oral Vaccines Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Oral Vaccines Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Oral Vaccines Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Oral Vaccines Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
